Aktiesnakken — Marts 2016
-
Jeg har begge aktier. Det fungerer godt for mig.
-
Der er mest potentiale i Genmab.
-
Følg den i Genmabchatten og spørg der.
-
Min kommentar på Børsen Play omkring Seadrill: http://play.borsen.dk/social/56d95e4e725ed7540a0cfd55
-
Til dem der ønsker kilde http://www.novonordisk.com/media/news-details.1991879.html
-
Super gode LEADER data
-
Fedt.

-
Forhåbentlig kan vi snart
ramme 400 igen -
En positiv nyhed der ikke var indregnet vil jeg næsten kalde verdens ottende vidunder. Dejlig nyhed op til weekenden.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
er selv inde i Vestas , Genmab og Novo ... Banken rykker for at jeg får nulstillet min aktieudbytte skat... Uha
: Victoza
significantly reduces the risk of major adverse cardiovascular events in the LEADER trial